|
2024
|
Invention
|
Fusion proteins for inhibiting angiogenesis.
The present invention relates to a biologic that in... |
|
|
Invention
|
Ophthalmic formulations of tyrosine kinase inhibitors, methods of use thereof, and preparation me... |
|
|
Invention
|
Use of an agonist of formyl peptide receptors 1 and 2 for treating ocular inflammatory diseases. ... |
|
2023
|
Invention
|
Vegfr fusion protein pharmaceutical composition. The present invention relates to a biologic that... |
|
2020
|
Invention
|
Fusion proteins for inhibiting angiogenesis. The present invention relates to a biologic that inh... |
|
2019
|
Invention
|
Crystalline forms of 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-phen... |
|
2018
|
P/S
|
Medicines for the treatment of ophthalmic and central nervous system (CNS) diseases for human pur... |
|
2017
|
Invention
|
Crystal forms of 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-phenylam... |
|
2016
|
Invention
|
Compounds and their use as bace1 inhibitors. 6, are as defined in the specification and claims. T... |
|
|
Invention
|
Compounds and their use as bace1 inhibitors. The present invention relates to compounds of Formul... |
|
|
Invention
|
Fusion protein comprising a ligand binding domain of vegf and pdgf. Fusion proteins containing a ... |
|
2015
|
P/S
|
Pharmaceutical preparations; nutritional supplements; disinfectants for hygiene purposes; surgica... |
|
|
P/S
|
Chemical research; chemical analysis; [ cosmetics research; ] biological research; [ bacteriologi... |
